TrueMark Investments’s GSK GSK Stock Holding History

TrueMark Investments’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.71M	Sell	108,899 -6,423	-6%	-$340K	0.72%	42
2026 Q1	$6.36M	Buy	115,322 +14,190	+14%	+$769K	1.24%	35
2025 Q4	$4.96M	Buy	101,132 +13,158	+15%	+$614K	0.95%	39
2025 Q3	$3.8M	Buy	87,974 +4,832	+6%	+$189K	0.66%	61
2025 Q2	$3.19M	Buy	83,142 +12,880	+18%	+$492K	0.69%	60
2025 Q1	$2.72M	Buy	+70,262	New	+$2.57M	0.71%	48

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

TrueMark Investments's GSK Position: Q2 2026 in Review

TrueMark Investments reduced its GSK (GSK) stake by 5.6% in Q2 2026, selling an estimated $340K and leaving 108,899 shares worth $5.71M. The position accounts for 0.72% of the portfolio, ranked #42.

TrueMark Investments first reported a position in GSK in Q1 2025 and has held it in 6 quarters since. The position peaked at $6.36M in Q1 2026. 1,045 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

TrueMark Investments held 108,899 shares of GSK worth $5.71M as of Q2 2026.
TrueMark Investments sold 6,423 GSK shares in Q2 2026, an estimated $340K.
GSK made up 0.72% of TrueMark Investments's portfolio in Q2 2026, its #42 holding.
TrueMark Investments first reported a position in GSK in Q1 2025 and has held it in 6 quarters since.
TrueMark Investments's GSK position peaked at $6.36M in Q1 2026.
1,045 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on TrueMark Investments's 13F filing for Q2 2026, filed 22 Jul 2026.